Trial intelligence / Profile preview

Sublingual vs Vaginal Misoprostol for Missed Abortion

NCT05001061Phase 1Unknown

Sponsor
Cairo University
Start
Aug 2021
Primary completion
Oct 2021
Modality
Small Molecules
01

Overview

Phase 1, randomised, open-label trial of misoprostol in missed abortion (2 arms), sponsored by Cairo University. Primary endpoints: The occurance of complete abortion within 24 hours with Misoprostol drug and Which route is the best and less side effects in complete termination of first trimester missed abortion by Misoprostol drug at 24 hours. Status: unknown.

02

Drugs

misoprostol
03

Conditions

missed abortion

Beyond the preview

Go deeper on NCT05001061.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05001061.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call